Hidradenitis suppurativa and adalimumab in the COVID-19 era | Zendy

Angelo Valerio Marzano | Zendy; Chiara Moltrasio | Zendy; Giovanni Genovese | Zendy; Simona Muratori | Zendy; Paolo Dapavo | Zendy; Gabriella Fabbrocini | Zendy; Annalisa Patrizi | Zendy; Andrea Sechi | Zendy; Giuseppe Micali | Zendy; Michele Pellegrino | Zendy; Paolo Gisondi | Zendy; Valentina Dini | Zendy; Luca Bianchi | Zendy; Luca Fania | Zendy; Annamaria Offidani | Zendy; Francesca Prignano | Zendy; Laura Atzori | Zendy; Emanuele Miraglia | Zendy; Serafinella Patrizia Cannavò | Zendy; Vincenzo Bettoli | Zendy; Luca Stingeni | Zendy; Riccardo Balestri | Zendy; Marina Venturini | Zendy; Ketty Peris | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hidradenitis suppurativa and adalimumab in the COVID-19 era

Author(s) -

Angelo Valerio Marzano,

Chiara Moltrasio,

Giovanni Genovese,

Simona Muratori,

Paolo Dapavo,

Gabriella Fabbrocini,

Annalisa Patrizi,

Andrea Sechi,

Giuseppe Micali,

Michele Pellegrino,

Paolo Gisondi,

Valentina Dini,

Luca Bianchi,

Luca Fania,

Annamaria Offidani,

Francesca Prignano,

Laura Atzori,

Emanuele Miraglia,

Serafinella Patrizia Cannavò,

Vincenzo Bettoli,

Luca Stingeni,

Riccardo Balestri,

Marina Venturini,

Ketty Peris

Publication year - 2020

Publication title -

european journal of dermatology

Language(s) - English

Resource type - Journals

eISSN - 1952-4013

pISSN - 1167-1122

DOI - 10.1684/ejd.2020.3927

Subject(s) - hidradenitis suppurativa , adalimumab , medicine , covid-19 , dermatology , betacoronavirus , medline , coronavirus infections , virology , tumor necrosis factor alpha , disease , outbreak , infectious disease (medical specialty) , political science , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research